Logo

Recovering from BIO

Jun 26, 2008

Now that everyone's home from the BIO annual meeting, bloggers are catching up. At the Periodic Tabloid, Tom Tritton says that the Biotechnology Heritage Award given at the conference was well deserved by Genzyme's Henri Termeer.

Meanwhile, Stephen Albainy-Jenei has a post at Patent Baristas on a talk from Elizabeth Edwards, who discussed what a better healthcare system would look like.

 

Breaking News
The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.